- Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients. Loudon, P.T., Blakeley, D.M., Boursnell, M.E., Day, D.A., Duncan, I.A., Lowden, R.C., McLean, C.S., Martin, G., Miller, J.C., Shaw, M.L. The journal of gene medicine. (2001)